Characterization and Phenotyping of Patients Who Are Offered Drug Therapy for Obesity
Recruiting now
Conditions studied: Obesity & Overweight
In brief
The study is multicenter and observational, consisting of a cross-sectional phase (V0) in which data will be collected from patients who are offered drug therapy, and a prospective longitudinal phase in which only patients who agree to start drug therapy for obesity will be involved
Key facts
- Study ID
- NCT07414043
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- People needed
- 500
- Starts
- 2025-10-22
- Expected to finish
- 2036-06-30
- Last updated by the study team
- 2026-02-17
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Bologna, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.